首页> 美国卫生研究院文献>Cellular Reprogramming >Effects of Histone Deacetylase Inhibitor Oxamflatin on In Vitro Porcine Somatic Cell Nuclear Transfer Embryos
【2h】

Effects of Histone Deacetylase Inhibitor Oxamflatin on In Vitro Porcine Somatic Cell Nuclear Transfer Embryos

机译:组蛋白脱乙酰基酶抑制剂Oxamflatin对体外猪体细胞核移植胚胎的影响

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Low cloning efficiency is considered to be caused by the incomplete or aberrant epigenetic reprogramming of differentiated donor cells in somatic cell nuclear transfer (SCNT) embryos. Oxamflatin, a novel class of histone deacetylase inhibitor (HDACi), has been found to improve the in vitro and full-term developmental potential of SCNT embryos. In the present study, we studied the effects of oxamflatin treatment on in vitro porcine SCNT embryos. Our results indicated that the rate of in vitro blastocyst formation of SCNT embryos treated with 1 μM oxamflatin for 15 h postactivation was significantly higher than all other treatments. Treatment of oxamflatin decreased the relative histone deacetylase (HDAC) activity in cloned embryos and resulted in hyperacetylation levels of histone H3 at lysine 9 (AcH3K9) and histone H4 at lysine 5 (AcH4K5) at pronuclear, two-cell, and four-cell stages partly through downregulating HDAC1. The suppression of HDAC6 through oxamflatin increased the nonhistone acetylation level of α-tubulin during the mitotic cell cycle of early SCNT embryos. In addition, we demonstrated that oxamflatin downregulated DNA methyltransferase 1 (DNMT1) expression and global DNA methylation level (5-methylcytosine) in two-cell-stage porcine SCNT embryos. The pluripotency-related gene POU5F1 was found to be upregulated in the oxamflatin-treated group with a decreased DNA methylation tendency in its promoter regions. Treatment of oxamflatin did not change the locus-specific DNA methylation levels of Sus scrofa heterochromatic satellite DNA sequences at the blastocyst stage. Meanwhile, our findings suggest that treatment with HDACi may contribute to maintaining the stable status of cytoskeleton-associated elements, such as acetylated α-tubulin, which may be the crucial determinants of donor nuclear reprogramming in early SCNT embryos. In summary, oxamflatin treatment improves the developmental potential of porcine SCNT embryos in vitro.
机译:克隆效率低被认为是由于体细胞核移植(SCNT)胚胎中分化的供体细胞的表观遗传重编程不完全或异常引起的。 Oxamflatin是一类新型的组蛋白脱乙酰基酶抑制剂(HDACi),已发现可改善SCNT胚胎的体外和足月发育潜能。在当前的研究中,我们研究了奥沙米丁治疗对体外猪SCNT胚胎的影响。我们的结果表明,用1μM的奥沙坦汀处理15个小时后活化的SCNT胚,体外胚泡形成的速率显着高于所有其他处理。奥沙普沙汀的处理降低了克隆胚胎中的相对组蛋白脱乙酰酶(HDAC)活性,导致原核,两细胞和四细胞阶段赖氨酸9(AcH3K9)的组蛋白H3和赖氨酸5(AcH4K5)的组蛋白H4的超乙酰化水平部分是通过下调HDAC1。在早期SCNT胚胎的有丝分裂细胞周期中,通过奥沙普丁抑制HDAC6可增加α-微管蛋白的非组蛋白乙酰化水平。此外,我们证明了氧嘧啶黄素下调了两细胞阶段猪SCNT胚胎中的DNA甲基转移酶1(DNMT1)表达和总体DNA甲基化水平(5-methylcytosine)。发现多能性相关基因POU5F1在奥沙坦汀治疗组中被上调,其启动子区域的DNA甲基化趋势降低。奥沙平治疗在囊胚期不改变Sus scrofa异色卫星DNA序列的基因座特异性DNA甲基化水平。同时,我们的发现表明,用HDACi进行治疗可能有助于维持细胞骨架相关元素(如乙酰化的α-微管蛋白)的稳定状态,这可能是早期SCNT胚胎中供体核重编程的关键决定因素。综上所述,奥沙坦汀治疗可提高猪SCNT体外胚胎的发育潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号